Sees 2023 adjusted net loss ($195M)-($145M) vs. prior ($85M)-($35M).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EBS:
- Emergent BioSolutions Reports Financial Results for Second Quarter 2023
- Emergent BioSolutions eliminates COO role
- Emergent BioSolutions de-emphasizing focus on CDMO services, cuts 400 employees
- Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
- Biotech Alert: Searches spiking for these stocks today